Total Payments
$291,287
2024 Payments
$15,038
Companies
19
Transactions
385
Medicare Patients
17,924
Medicare Billing
$2.9M
Payment Breakdown by Category
Other$277,160 (95.2%)
Travel$7,419 (2.5%)
Food & Beverage$6,347 (2.2%)
Consulting$300.00 (0.1%)
Education$60.27 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $277,160 | 139 | 95.2% |
| Travel and Lodging | $7,419 | 51 | 2.5% |
| Food and Beverage | $6,347 | 189 | 2.2% |
| Consulting Fee | $300.00 | 1 | 0.1% |
| Education | $60.27 | 5 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $273,497 | 308 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $16,647 | 35 | $0 (2024) |
| CVRx, Inc. | $208.09 | 2 | $0 (2024) |
| Medtronic Vascular, Inc. | $189.41 | 7 | $0 (2020) |
| Abbott Laboratories | $141.74 | 3 | $0 (2022) |
| iRhythm Technologies, Inc. | $109.87 | 4 | $0 (2024) |
| Novo Nordisk Inc | $95.36 | 4 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $77.83 | 4 | $0 (2019) |
| E.R. Squibb & Sons, L.L.C. | $47.93 | 3 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $43.53 | 3 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $15,038 | 24 | Janssen Pharmaceuticals, Inc ($14,604) |
| 2023 | $12,357 | 19 | Janssen Pharmaceuticals, Inc ($12,289) |
| 2022 | $54,160 | 78 | Janssen Pharmaceuticals, Inc ($53,924) |
| 2021 | $15,175 | 38 | Janssen Pharmaceuticals, Inc ($15,146) |
| 2020 | $11,866 | 12 | Janssen Pharmaceuticals, Inc ($11,782) |
| 2019 | $42,150 | 44 | Janssen Pharmaceuticals, Inc ($41,982) |
| 2018 | $69,373 | 88 | Janssen Pharmaceuticals, Inc ($66,467) |
| 2017 | $71,167 | 82 | Janssen Pharmaceuticals, Inc ($57,304) |
All Payment Transactions
385 individual payment records from CMS Open Payments — Page 1 of 16
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $24.05 | General |
| Category: Obesity | ||||||
| 12/03/2024 | iRhythm Technologies, Inc. | ZIO XT Patch (Device), Zio monitor | Food and Beverage | In-kind items and services | $16.76 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/12/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $22.51 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/23/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $14.52 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/22/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $27.52 | General |
| Category: Diabetes | ||||||
| 10/15/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $19.79 | General |
| Category: Diabetes | ||||||
| 09/17/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $24.00 | General |
| Category: Diabetes | ||||||
| 09/10/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $18.40 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 07/09/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $19.39 | General |
| Category: Cardiovascular | ||||||
| 06/26/2024 | CVRx, Inc. | Barostim Neo System (Device) | Food and Beverage | Cash or cash equivalent | $41.34 | General |
| Category: Heart Failure and Hypertension | ||||||
| 06/14/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,120.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/13/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Travel and Lodging | In-kind items and services | $1,098.23 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/11/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $73.27 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/05/2024 | CVRx, Inc. | Barostim Neo System (Device) | Food and Beverage | Cash or cash equivalent | $166.75 | General |
| Category: Heart Failure and Hypertension | ||||||
| 05/20/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Travel and Lodging | In-kind items and services | $5.50 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 05/03/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,605.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 05/02/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Travel and Lodging | In-kind items and services | $5.50 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 04/22/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,030.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/20/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $16.31 | General |
| Category: Cardiology | ||||||
| 03/19/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,030.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/11/2024 | Medtronic, Inc. | TURBOHAWK (Device) | Food and Beverage | In-kind items and services | $22.72 | General |
| Category: Directional Atherectomy Devices | ||||||
| 02/26/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,605.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 02/26/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Travel and Lodging | Cash or cash equivalent | $26.80 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 02/14/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $4.59 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 12/06/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,465.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 42 | 5,712 | 18,832 | $5.0M | $1.0M |
| 2022 | 43 | 4,569 | 9,983 | $3.4M | $737,889 |
| 2021 | 36 | 3,844 | 8,359 | $2.6M | $574,757 |
| 2020 | 37 | 3,799 | 9,184 | $2.7M | $564,691 |
Total Patients
17,924
Total Services
46,358
Medicare Billing
$2.9M
Procedure Codes
160
All Medicare Procedures & Services
160 procedure records from CMS Medicare Utilization — Page 1 of 7
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 78492 | Nuclear medicine studies of blood flow in heart muscle at rest and with stress | Office | 2023 | 233 | 234 | $1.2M | $267,573 | 22.9% |
| A9555 | Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | Office | 2023 | 233 | 467 | $1.2M | $145,321 | 12.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 1,160 | 1,687 | $253,050 | $143,686 | 56.8% |
| A9502 | Technetium tc-99m tetrofosmin, diagnostic, per study dose | Office | 2023 | 120 | 240 | $109,920 | $83,212 | 75.7% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 375 | 387 | $493,829 | $52,843 | 10.7% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 286 | 1,139 | $113,900 | $49,882 | 43.8% |
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Office | 2023 | 56 | 56 | $328,216 | $43,656 | 13.3% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 121 | 121 | $236,336 | $38,781 | 16.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 416 | 487 | $53,570 | $29,558 | 55.2% |
| 93459 | Insertion of tube in left lower heart chamber, coronary artery and bypass graft for diagnosis with review by radiologist | Office | 2023 | 23 | 23 | $145,153 | $19,790 | 13.6% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 347 | 352 | $116,864 | $16,725 | 14.3% |
| 92928 | Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | Facility | 2023 | 26 | 29 | $94,743 | $13,068 | 13.8% |
| 93970 | Ultrasound study of arm or leg veins with compression and maneuvers | Office | 2023 | 92 | 93 | $50,220 | $12,745 | 25.4% |
| 93460 | Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist | Office | 2023 | 13 | 13 | $89,193 | $12,179 | 13.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 93 | 93 | $19,995 | $10,853 | 54.3% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 60 | 122 | $12,200 | $7,626 | 62.5% |
| 36471 | Injection of chemical agent into multiple incompetent veins of leg | Office | 2023 | 13 | 49 | $29,400 | $7,021 | 23.9% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2023 | 28 | 184 | $27,600 | $6,713 | 24.3% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 613 | 646 | $51,680 | $6,229 | 12.1% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 47 | 56 | $9,801 | $5,370 | 54.8% |
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 23 | 23 | $94,668 | $4,750 | 5.0% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2023 | 25 | 123 | $22,140 | $4,489 | 20.3% |
| G2066 | Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | Office | 2023 | 35 | 162 | $20,250 | $4,132 | 20.4% |
| 93294 | Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | Office | 2023 | 76 | 196 | $17,640 | $4,037 | 22.9% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 18 | 42 | $5,460 | $3,956 | 72.4% |
About Dr. Bruce Stein, MD
Dr. Bruce Stein, MD is a Cardiovascular Disease healthcare provider based in Orlando, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/09/2005. The National Provider Identifier (NPI) number assigned to this provider is 1790779320.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Bruce Stein, MD has received a total of $291,287 in payments from pharmaceutical and medical device companies, with $15,038 received in 2024. These payments were reported across 385 transactions from 19 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($277,160).
As a Medicare-enrolled provider, Stein has provided services to 17,924 Medicare beneficiaries, totaling 46,358 services with total Medicare billing of $2.9M. Data is available for 4 years (2020–2023), covering 160 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Other Specialties Interventional Cardiology
- Location Orlando, FL
- Active Since 09/09/2005
- Last Updated 03/13/2015
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1790779320
Products in Payments
- XARELTO (Drug) $273,494
- ENTRESTO (Drug) $16,567
- Barostim Neo System (Device) $208.09
- AVEIR (Device) $96.21
- ZIO Patch (Device) $93.11
- ClosureFast (Device) $84.82
- Reveal LINQ (Device) $83.63
- LEQVIO (Drug) $79.70
- Ozempic (Drug) $71.31
- MULTAQ (Drug) $53.32
- PRALUENT (Biological) $43.53
- Optimizer (Device) $42.10
- Repatha (Biological) $37.68
- VERQUVO (Drug) $34.79
- ELIQUIS (Drug) $28.54
- SYNVISC-ONE (Device) $24.51
- CARDIOMEMS (Device) $24.06
- Wegovy (Drug) $24.05
- CATHETERS - ARROW (Device) $22.94
- TURBOHAWK (Device) $22.72
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Orlando
Naveen Bellam, M.d, M.D
Cardiovascular Disease — Payments: $315,652
Cardiovascular Disease $315,652
Carlos Zamora, M.d, M.D
Cardiovascular Disease — Payments: $215,909
Cardiovascular Disease $215,909
Nirav Raval, Md, MD
Cardiovascular Disease — Payments: $171,358
Cardiovascular Disease $171,358
James Tarver, M.d, M.D
Cardiovascular Disease — Payments: $133,743
Cardiovascular Disease $133,743
Aurelio Duran, M.d, M.D
Cardiovascular Disease — Payments: $110,928
Cardiovascular Disease $110,928
Aalok Patel, M.d, M.D
Cardiovascular Disease — Payments: $97,705
Cardiovascular Disease $97,705